HK Stock MarketDetailed Quotes
02196 FOSUN PHARMA
- 16.840
- +1.300+8.37%
Market Closed Oct 4 16:08 CST
44.91BMarket Cap22.28P/E (TTM)
16.860High15.380Low7.12MVolume15.660Open15.540Pre Close116.28MTurnover1.30%Turnover Ratio16.98P/E (Static)2.67BShares18.72052wk High0.87P/B9.20BFloat Cap11.02052wk Low0.30Dividend TTM546.47MShs Float80.580Historical High0.301Dividend LFY9.52%Amplitude5.897Historical Low16.332Avg Price500Lot Size1.79%Div YieldTTM1.79%Div Yield LFY
FOSUN PHARMA Key Stats
All
YOY
| (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | (Q3)Mar 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | ---- | ---- | -28.46%3.28B | ---- | ---- | ---- | -24.20%4.58B | ---- | ---- | ---- |
| Profit adjustment | ||||||||||
| Interest (income) - adjustment | ---- | ---- | -0.37%-155.58M | ---- | ---- | ---- | -67.90%-155.01M | ---- | ---- | ---- |
| Dividend (income)- adjustment | ---- | ---- | 2.74%-61.44M | ---- | ---- | ---- | -31.88%-63.17M | ---- | ---- | ---- |
| Attributable subsidiary (profit) loss | ---- | ---- | -19.06%-2.18B | ---- | ---- | ---- | -2.57%-1.84B | ---- | ---- | ---- |
| Impairment and provisions: | ---- | ---- | 4.09%351.67M | ---- | ---- | ---- | -62.62%337.86M | ---- | ---- | ---- |
| -Impairment of property, plant and equipment (reversal) | ---- | ---- | -41.17%2.41M | ---- | ---- | ---- | --4.09M | ---- | ---- | ---- |
| -Impairmen of inventory (reversal) | ---- | ---- | 40.56%121.34M | ---- | ---- | ---- | 33.61%86.33M | ---- | ---- | ---- |
| -Impairment of goodwill | ---- | ---- | ---- | ---- | ---- | ---- | 20.00%180M | ---- | ---- | ---- |
| -Other impairments and provisions | ---- | ---- | 237.97%227.92M | ---- | ---- | ---- | -90.22%67.44M | ---- | ---- | ---- |
| Revaluation surplus: | ---- | ---- | -82.89%427.38M | ---- | ---- | ---- | 669.45%2.5B | ---- | ---- | ---- |
| -Other fair value changes | ---- | ---- | -82.89%427.38M | ---- | ---- | ---- | 669.45%2.5B | ---- | ---- | ---- |
| Asset sale loss (gain): | ---- | ---- | 51.15%-1.27B | ---- | ---- | ---- | 2.61%-2.6B | ---- | ---- | ---- |
| -Loss (gain) from sale of subsidiary company | ---- | ---- | -99.27%-709.55M | ---- | ---- | ---- | 86.81%-356.08M | ---- | ---- | ---- |
| -Loss (gain) on sale of property, machinery and equipment | ---- | ---- | 99.52%-538K | ---- | ---- | ---- | -430.65%-111.28M | ---- | ---- | ---- |
| -Loss (gain) from selling other assets | ---- | ---- | 73.78%-558.49M | ---- | ---- | ---- | ---2.13B | ---- | ---- | ---- |
| Depreciation and amortization: | ---- | ---- | 27.42%3.12B | ---- | ---- | ---- | 25.62%2.45B | ---- | ---- | ---- |
| -Amortization of intangible assets | ---- | ---- | 36.86%1.28B | ---- | ---- | ---- | 65.08%937.2M | ---- | ---- | ---- |
| Financial expense | ---- | ---- | 37.46%1.32B | ---- | ---- | ---- | 17.17%963.81M | ---- | ---- | ---- |
| Special items | ---- | ---- | -17.43%35.62M | ---- | ---- | ---- | -32.83%43.14M | ---- | ---- | ---- |
| Operating profit before the change of operating capital | ---- | ---- | -21.80%4.86B | ---- | ---- | ---- | 31.05%6.22B | ---- | ---- | ---- |
| Change of operating capital | ||||||||||
| Inventory (increase) decrease | ---- | ---- | 76.65%-333.91M | ---- | ---- | ---- | -207.71%-1.43B | ---- | ---- | ---- |
| Accounts receivable (increase)decrease | ---- | ---- | 124.25%396.15M | ---- | ---- | ---- | -4.74%-1.63B | ---- | ---- | ---- |
| Accounts payable increase (decrease) | ---- | ---- | -178.65%-1.33B | ---- | ---- | ---- | -40.99%1.69B | ---- | ---- | ---- |
| prepayments (increase)decrease | ---- | ---- | 41.14%741.28M | ---- | ---- | ---- | 220.35%525.22M | ---- | ---- | ---- |
| Special items for working capital changes | ---- | ---- | 94.45%-25.77M | ---- | ---- | ---- | -29.71%-464.38M | ---- | ---- | ---- |
| Cash from business operations | 1.65%2.37B | ---- | -12.10%4.31B | ---- | 6.04%2.33B | ---- | 2.44%4.91B | ---- | 5.05%2.2B | ---- |
| Other taxs | 11.20%-464.5M | ---- | -30.40%-899.66M | ---- | -30.29%-523.11M | ---- | 19.12%-689.9M | ---- | -3.56%-401.48M | ---- |
| Adjustment items of business operations | ---- | 5.05%917.31M | ---- | -21.70%2.46B | ---- | 2.06%873.24M | ---- | 4.24%3.14B | ---- | 16.13%855.61M |
| Net cash from operations | 5.36%1.91B | 5.05%917.31M | -19.05%3.41B | -21.70%2.46B | 0.63%1.81B | 2.06%873.24M | 7.10%4.22B | 4.24%3.14B | 5.39%1.8B | 16.13%855.61M |
| Cash flow from investment activities | ||||||||||
| Dividend received - investment | 89.65%154.04M | 32.08%138.61M | 7.42%770.73M | 13.71%888.39M | -7.59%81.22M | 554.77%104.94M | 8.34%717.5M | 21.24%781.24M | 27.08%87.89M | -15.51%16.03M |
| Loan receivable (increase) decrease | ---- | ---- | -133.84%-60.46M | ---- | -137.47%-60.46M | ---- | 566.74%178.67M | ---- | --161.37M | ---- |
| Decrease in deposits (increase) | -122.28%-305.54M | ---- | 158.90%650.97M | ---- | 204.67%1.37B | ---- | -164.68%-1.11B | ---- | -59.97%-1.31B | ---- |
| Sale of fixed assets | 193.23%8.71M | -48.22%1.17M | -91.59%9.01M | -94.86%7.18M | -97.14%2.97M | -95.66%2.26M | 10.33%107.13M | 47.31%139.77M | 462.87%103.69M | 2,675.90%52.12M |
| Purchase of fixed assets | 28.86%-2.09B | 26.34%-1.25B | 9.38%-5.34B | 5.78%-4.22B | -13.38%-2.94B | -13.61%-1.7B | -18.42%-5.89B | -27.83%-4.48B | -13.53%-2.6B | -17.55%-1.5B |
| Sale of subsidiaries | --134.05M | --138.27M | -99.96%300K | ---- | ---- | ---- | -76.02%709.21M | 16.82%704.49M | 196.49%704.49M | --385.27M |
| Acquisition of subsidiaries | 56.82%-593.61M | ---- | 4.62%-1.6B | 3.42%-1.15B | -96.64%-1.37B | 89.64%-47.59M | -0.86%-1.68B | -860.18%-1.19B | -475.15%-699.17M | -26,154.35%-459.45M |
| Recovery of cash from investments | -94.13%39.15M | -96.09%19.4M | -51.44%1.86B | -51.40%971.68M | -46.92%666.84M | -55.54%496.38M | 1,518.84%3.83B | 106.84%2B | 1,339.41%1.26B | 128.81%1.12B |
| Cash on investment | 57.97%-86.41M | 56.02%-37.18M | 69.58%-310.98M | 19.82%-691.32M | 18.45%-205.57M | 70.17%-84.55M | -17.88%-1.02B | -35.62%-862.2M | -31.46%-252.07M | -109.12%-283.4M |
| Other items in the investment business | -5.81%93.03M | -117.99%-196.94M | 126.69%198.91M | 169.25%902.59M | 69.83%98.76M | 237.19%1.09B | 3.89%87.75M | -105.71%-1.3B | -89.55%58.15M | -18.90%-797.79M |
| Net cash from investment operations | -12.19%-2.65B | -768.33%-1.19B | 6.02%-3.82B | 21.85%-3.28B | 4.96%-2.36B | 90.67%-137.18M | -5.35%-4.06B | -62.55%-4.2B | -1.45%-2.49B | 6.67%-1.47B |
| Net cash before financing | -34.59%-742.94M | -137.20%-273.82M | -363.83%-405.07M | 22.31%-822.65M | 19.60%-552.02M | 219.86%736.07M | 91.14%153.53M | -346.02%-1.06B | 7.61%-686.56M | 26.71%-614.12M |
| Cash flow from financing activities | ||||||||||
| New borrowing | 16.20%15.87B | 16.06%7.99B | -22.79%23.18B | -27.11%18.05B | -23.55%13.66B | -8.31%6.88B | 2.70%30.02B | 16.52%24.77B | 25.53%17.87B | 6.71%7.51B |
| Refund | -36.63%-15.73B | -22.00%-7.63B | 17.09%-21.79B | 25.19%-15.55B | 10.89%-11.51B | -27.70%-6.25B | 4.06%-26.28B | -4.57%-20.78B | -1.57%-12.92B | 11.07%-4.9B |
| Issuing shares | ---- | ---- | -99.82%7.91M | ---- | ---- | ---- | --4.51B | ---- | ---- | ---- |
| Interest paid - financing | -6.26%-664.3M | ---- | -42.03%-1.33B | ---- | -39.47%-625.16M | ---- | -15.61%-937.34M | ---- | -6.83%-448.22M | ---- |
| Dividends paid - financing | -16.34%-182.34M | -5.84%-344.87M | 15.87%-1.33B | -1.38%-2.28B | 88.88%-156.73M | -41.13%-325.84M | -13.17%-1.58B | -21.81%-2.25B | -1,942.64%-1.41B | 23.32%-230.88M |
| Absorb investment income | -20.07%212.07M | 562.89%114.18M | -37.11%362.92M | -99.04%43.94M | -41.43%265.32M | -27.45%17.23M | -52.10%577.04M | 476.81%4.58B | 80.23%453.03M | -85.42%23.74M |
| Other items of the financing business | 1,614.23%1.78B | 23.96%-29.61M | 89.21%-182.13M | 50.40%-662.17M | 88.43%-117.54M | 95.42%-38.94M | -13.57%-1.69B | -24.86%-1.34B | -131.16%-1.02B | -354.25%-849.55M |
| Net cash from financing operations | -22.10%1.09B | -65.02%98.64M | -130.17%-1.34B | -107.97%-396.58M | -42.65%1.4B | -81.85%281.97M | 640.45%4.43B | 767.80%4.97B | 217.17%2.44B | 29.13%1.55B |
| Effect of rate | -58.64%17.13M | 134.79%23.44M | -42.62%73.65M | -58.87%131.33M | -39.16%41.42M | -43.31%-67.37M | 195.27%128.34M | 521.01%319.32M | 165.92%68.08M | -266.37%-47.01M |
| Net Cash | -59.00%347.62M | -117.21%-175.18M | -138.00%-1.74B | -131.15%-1.22B | -51.68%847.89M | 8.40%1.02B | 719.96%4.58B | 1,345.33%3.91B | 6,504.56%1.75B | 157.33%939.19M |
| Begining period cash | -14.93%9.5B | -14.93%9.5B | 72.92%11.17B | 72.92%11.17B | 72.92%11.17B | 72.92%11.17B | -11.92%6.46B | -11.81%6.46B | -11.81%6.46B | -11.81%6.46B |
| Cash at the end | -18.18%9.87B | -22.85%9.35B | -14.93%9.5B | -5.71%10.08B | 45.60%12.06B | 64.87%12.12B | 72.92%11.17B | 54.20%10.69B | 14.27%8.28B | -4.74%7.35B |
| Cash balance analysis | ||||||||||
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | HKAS | CAS (2007) | HKAS | CAS (2007) | HKAS | CAS (2007) | HKAS | CAS (2007) | HKAS | CAS (2007) |
| Audit Opinions | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- | -- |
| Auditor | -- | -- | Ernst & Young (Special General Partnership) | -- | -- | -- | Ernst & Young (Special General Partnership) | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Analysis
Price Target
No Data
Heat List
HK
Overall
Symbol
Latest Price
% Chg
No Data